Last reviewed · How we verify

NCT03734250

D Vitamin Effects on Neuromuscular Blocker Reverse Time

Completed Last updated 7 November 2018
What this trial tests

trial in Vitamin D Deficiency in 84 participants. Completed in 1 March 2018.

Timeline
1 November 2014
Primary endpoint
1 March 2018
1 March 2018

Quick facts

Lead sponsorDuzce University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment84
Start date1 November 2014
Primary completion1 March 2018
Estimated completion1 March 2018

Conditions studied

Sponsor

Duzce University

Who can join

Adults 18 to 65, any sex, with Vitamin D Deficiency or Neuromuscular Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background/aim: Investigators aimed to investigate the effect of D vitamin levels on Sugammadex and Neostigmine reverse durations in the study. Materials and methods: Eighty patients between 18 and 65 years, with ASA I-III status who were undergoing surgery under general anaesthesia were included the study. All patients were randomly divided into two groups with double blindness and 1.25 (OH) 2 vitamin D, 25 (OH) 2 vitamin D, and calcium levels were measured. At the end of the operation, 2 mg/kg of Sugammadex was administered to one group and Atropine + Neostigmine to the other group. The patients were also divided into two groups as to whether their vitamin D levels were ≥ 30 ng/mL or below. A train of four values was recorded after a hypnotic agent was given at the beginning and throughout the operation. The time to complete the disappearance of response to TOF stimulation was recorded as T0. End of the operation: When 2 responses to TOF stimulation were taken, the following times were recorded until the extubation phase by administering at least 2 mg/kg of Sugammadex or 0.05 mg/kg of Neostigmine 0.05 mg/kg of Atropine per kg of body weight. The time until the TOF value reached 50,70,90% and extubation were recorded.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effect of vitamin D status on different neuromuscular blocker agents reverse time
    Yorulmaz IS, Demiraran Y, Özlü O, Dost B. · · 2020 · cited 2× · PMID 32151115 · DOI 10.3906/sag-1901-115

Verify or expand the search:

Other recruiting trials for Vitamin D Deficiency

Currently open trials in the same condition.

Other Duzce University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03734250.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing